| 2024-03-11 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Medical Officer | 3,712 0.0038% | $65.59 | $243,482 | +3.8% | |
| 2024-03-07 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Medical Officer | 6,450 0.0066% | $66.56 | $429,308 | +1.83% | |
| 2024-02-26 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Medical Officer | 4,112 0.0042% | $70.17 | $288,534 | -5.04% | |
| 2024-02-02 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Medical Officer | 6,167 0.0063% | $67.19 | $414,355 | +1.75% | |
| 2024-01-02 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Medical Officer | 62,282 0.0647% | $70.60 | $4.4M | -3.2% | |
| 2023-12-13 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Medical Officer | 21,262 0.0217% | $65.00 | $1.38M | +3.67% | |
| 2023-07-17 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Medical Officer | 1,842 0.002% | $65.00 | $119,730 | +3.05% | |
| 2023-03-13 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Medical Officer | 7,344 0.0077% | $45.04 | $330,794 | +35.93% | |
| 2023-02-24 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP, Chief Medical Officer | 7,906 0.0083% | $47.14 | $372,689 | +27.97% | |
| 2023-02-21 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP, Chief Medical Officer | 8,354 0.0089% | $46.84 | $391,304 | +29.6% | |
| 2022-03-02 | Sale | Intra-Cellular Therapies, Inc. ITCI | Chief Medical Officer | 3,860 0.0041% | $55.52 | $214,307 | -8.48% | |
| 2022-02-24 | Sale | Intra-Cellular Therapies, Inc. ITCI | Chief Medical Officer | 4,046 0.0043% | $52.27 | $211,468 | -2.17% | |
| 2022-02-22 | Sale | Intra-Cellular Therapies, Inc. ITCI | Chief Medical Officer | 4,177 0.0046% | $55.29 | $230,958 | -3.92% | |
| 2022-01-18 | Sale | Intra-Cellular Therapies, Inc. ITCI | Chief Medical Officer | 6,223 0.007% | $42.03 | $261,553 | +31.18% | |
| 2022-01-10 | Sale | Intra-Cellular Therapies, Inc. ITCI | Chief Medical Officer | 6,870 0.0074% | $40.76 | $280,020 | +29.07% | |
| 2021-02-19 | Sale | Intra-Cellular Therapies, Inc. ITCI | Chief Medical Officer | 2,734 0.0034% | $39.25 | $107,310 | -4.23% | |
| 2021-01-11 | Sale | Intra-Cellular Therapies, Inc. ITCI | Chief Medical Officer | 4,367 0.0054% | $32.12 | $140,259 | +15.93% |